|
|
|
|
Дата |
|---|
| 08.10.2026 |
| 07.10.2026 |
| 06.10.2026 |
| 05.10.2026 |
| 02.10.2026 |
| 01.10.2026 |
| 30.09.2026 |
| 29.09.2026 |
| 28.09.2026 |
| 25.09.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
36 600.00
|
36 000.00
|
36 600.00
|
36 100.00
|
|
|
79 370 000.00
|
|
|
|
|
36 300.00
|
36 000.00
|
36 600.00
|
36 600.00
|
|
|
94 220 000.00
|
|
|
|
|
36 300.00
|
36 300.00
|
36 300.00
|
36 300.00
|
|
|
87 120 000.00
|
|
|
|
|
36 300.00
|
36 250.00
|
36 650.00
|
36 250.00
|
|
|
225 400 000.00
|
|
|
|
|
37 000.00
|
36 650.00
|
37 000.00
|
36 650.00
|
|
|
77 410 000.00
|
|
|
|
|
36 500.00
|
36 500.00
|
37 000.00
|
37 000.00
|
|
|
95 430 000.00
|
|
|
|
|
37 000.00
|
37 000.00
|
37 000.00
|
37 000.00
|
|
|
14 800 000.00
|
|
|
|
|
37 500.00
|
36 800.00
|
37 600.00
|
36 800.00
|
|
|
103 710 000.00
|
|
|
|
|
37 100.00
|
36 950.00
|
37 100.00
|
37 100.00
|
|
|
255 360 000.00
|
|
|
|
|
36 800.00
|
36 800.00
|
37 100.00
|
36 900.00
|
|
|
122 200 000.00
|
|
Период |
|---|
| 2025, регулярные |
| 2025, регулярные |
| 2024, регулярные |
| 2023, регулярные |
| 2023, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
21.07.2026
|
22.07.2026 |
2000 VND |
|
31.12.2025
|
05.01.2026 |
2000 VND |
|
13.06.2025
|
16.06.2025 |
2000 VND |
|
17.06.2024
|
18.06.2024 |
2000 VND |
|
16.01.2024
|
17.01.2024 |
2000 VND |
|
19.01.2021
|
20.01.2021 |
2000 VND |
|
01.01.2020
|
02.01.2020 |
2000 VND |
|
04.01.2019
|
07.01.2019 |
2000 VND |
|
27.12.2017
|
28.12.2017 |
2000 VND |
|
03.01.2017
|
04.01.2017 |
2000 VND |
Traphaco JSC is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry.
